Determine the necessary mass, volume, or concentration for preparing a solution.
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Pubchem Sid | 504754264 |
|---|---|
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/504754264 |
| Canonical Smiles | C(C(=O)O)SSCC(=O)O |
| IUPAC Name | 2-(carboxymethyldisulfanyl)acetic acid |
| InChIKey | DLLMHEDYJQACRM-UHFFFAOYSA-N |
| INCHI | 1S/C4H6O4S2/c5-3(6)1-9-10-2-4(7)8/h1-2H2,(H,5,6)(H,7,8) |
| Isomeric SMILES | C(C(=O)O)SSCC(=O)O |
| WGK Germany | 3 |
| Molecular Weight | 182.22 |
| Reaxy-Rn | 1771018 |
| Reaxys-RN_link_address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=1771018&ln= |
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organic acids and derivatives |
| Class | Carboxylic acids and derivatives |
| Subclass | Dicarboxylic acids and derivatives |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Dicarboxylic acids and derivatives |
| Alternative Parents | Dialkyldisulfides Sulfenyl compounds Carboxylic acids Organic oxides Hydrocarbon derivatives Carbonyl compounds |
| Molecular Framework | Aliphatic acyclic compounds |
| Substituents | Dicarboxylic acid or derivatives - Dialkyldisulfide - Organic disulfide - Sulfenyl compound - Carboxylic acid - Organic oxygen compound - Organic oxide - Hydrocarbon derivative - Organosulfur compound - Organooxygen compound - Carbonyl group - Aliphatic acyclic compound |
| Description | This compound belongs to the class of organic compounds known as dicarboxylic acids and derivatives. These are organic compounds containing exactly two carboxylic acid groups. |
| External Descriptors | Not available |
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | May 28, 2026 | D113563 | |
| Certificate of Analysis | May 28, 2026 | D113563 | |
| Certificate of Analysis | May 28, 2026 | D113563 | |
| Certificate of Analysis | Jul 28, 2025 | D113563 | |
| Certificate of Analysis | Jul 28, 2025 | D113563 | |
| Certificate of Analysis | Jul 28, 2025 | D113563 | |
| Certificate of Analysis | Jul 28, 2025 | D113563 | |
| Certificate of Analysis | Mar 07, 2025 | D113563 | |
| Certificate of Analysis | Mar 07, 2025 | D113563 | |
| Certificate of Analysis | Mar 07, 2025 | D113563 | |
| Certificate of Analysis | Mar 12, 2024 | D113563 | |
| Certificate of Analysis | Mar 12, 2024 | D113563 | |
| Certificate of Analysis | Mar 12, 2024 | D113563 | |
| Certificate of Analysis | Mar 12, 2024 | D113563 | |
| Certificate of Analysis | Mar 12, 2024 | D113563 | |
| Certificate of Analysis | Mar 12, 2024 | D113563 | |
| Certificate of Analysis | Mar 12, 2024 | D113563 | |
| Certificate of Analysis | Aug 22, 2023 | D113563 | |
| Certificate of Analysis | Aug 22, 2023 | D113563 | |
| Certificate of Analysis | Aug 22, 2023 | D113563 | |
| Certificate of Analysis | Aug 22, 2023 | D113563 | |
| Certificate of Analysis | Aug 22, 2023 | D113563 | |
| Certificate of Analysis | Aug 22, 2023 | D113563 | |
| Certificate of Analysis | Aug 22, 2023 | D113563 | |
| Certificate of Analysis | Feb 09, 2023 | D113563 | |
| Certificate of Analysis | Feb 09, 2023 | D113563 | |
| Certificate of Analysis | Dec 22, 2021 | D113563 |
| Solubility | Soluble in water; Soluble in Methanol,Ethanol,Ether |
|---|---|
| Melt Point(°C) | 107°C |
| Molecular Weight | 182.200 g/mol |
| XLogP3 | 0.100 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 5 |
| Exact Mass | 181.971 Da |
| Monoisotopic Mass | 181.971 Da |
| Topological Polar Surface Area | 125.000 Ų |
| Heavy Atom Count | 10 |
| Formal Charge | 0 |
| Complexity | 119.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 1 |
| 1. Yuting Liu, Xinhui Wang, Zhe Wang, Rui Liao, Qian Qiu, Yuequan Wang, Cong Luo. (2023) Reduction-Responsive Stearyl Alcohol-Cabazitaxel Prodrug Nanoassemblies for Cancer Chemotherapy. Pharmaceutics, 15 (1): (262). [PMID:36678891] [10.3390/pharmaceutics15010262] |
| 2. Min Cai, Xiaojun Li, Meng Xu, Shiqi Zhou, Lei Fan, Jingyan Huang, Cairong Xiao, Yichen Lee, Bo Yang, Le Wang, Ross William Crawford, Yin Xiao, Lei Zhou, Chengyun Ning, Yan Wang. (2022) Injectable Tumor Microenvironment-Modulated Hydrogels with Enhanced Chemosensitivity and Osteogenesis for Tumor-Associated Bone Defects Closed-Loop Management. CHEMICAL ENGINEERING JOURNAL, [PMID:] [10.1016/j.cej.2022.138086] |
| 3. Jie Yang, Siyu Ma, Rui Xu, Yawen Wei, Jun Zhang, Tiantian Zuo, Zhihua Wang, Huizi Deng, Ning Yang, Qi Shen. (2021) Smart biomimetic metal organic frameworks based on ROS-ferroptosis-glycolysis regulation for enhanced tumor chemo-immunotherapy. JOURNAL OF CONTROLLED RELEASE, [PMID:33872626] [10.1016/j.jconrel.2021.04.013] |
| 4. Xiao Kuang, Dongxu Chi, Jinbo Li, Chunlin Guo, Yinxian Yang, Shuang Zhou, Cong Luo, Hongzhuo Liu, Zhonggui He, Yongjun Wang. (2021) Disulfide bond based cascade reduction-responsive Pt(IV) nanoassemblies for improved anti-tumor efficiency and biosafety. COLLOIDS AND SURFACES B-BIOINTERFACES, [PMID:33866279] [10.1016/j.colsurfb.2021.111766] |
| 5. Lv Lingyan, Li Xinrui, Qian Wei, Li Shennan, Jiang Yan, Xiong Yaokun, Xu Jianpei, Lv Wei, Liu Xiaoyan, Chen Yun, Tang Yulin, Xin Hongliang. (2020) Enhanced Anti-Glioma Efficacy by Borneol Combined With CGKRK-Modified Paclitaxel Self-Assembled Redox-Sensitive Nanoparticles. Frontiers in Pharmacology, [PMID:32425792] [10.3389/fphar.2020.00558] |
| 6. Wang-Wei Guo, Zhen-Tao Zhang, QiChun Wei, Yi Zhou, Meng-Ting Lin, Jie-Jian Chen, Tian-Tian Wang, Ning-Ning Guo, Xin-Cheng Zhong, Yi-Ying Lu, Qi-Yao Yang, Min Han, JianQing Gao. (2019) Intracellular Restructured Reduced Glutathione-Responsive Peptide Nanofibers for Synergetic Tumor Chemotherapy. BIOMACROMOLECULES, [PMID:31851512] [10.1021/acs.biomac.9b01202] |
| 7. Yan Jiang, Xiuzhen Wang, Xin Liu, Wei Lv, Hongjuan Zhang, Mingwan Zhang, Xinrui Li, Hongliang Xin, Qunwei Xu. (2016) Enhanced Antiglioma Efficacy of Ultrahigh Loading Capacity Paclitaxel Prodrug Conjugate Self-Assembled Targeted Nanoparticles. ACS Applied Materials & Interfaces, [PMID:27976583] [10.1021/acsami.6b13805] |
| 8. Peng Xue, Dan Liu, Jing Wang, Na Zhang, Jiahua Zhou, Lin Li, Weiling Guo, Mengchi Sun, Xiangfei Han, Yongjun Wang. (2016) Redox-Sensitive Citronellol–Cabazitaxel Conjugate: Maintained in Vitro Cytotoxicity and Self-Assembled as Multifunctional Nanomedicine. BIOCONJUGATE CHEMISTRY, [PMID:27070505] [10.1021/acs.bioconjchem.6b00155] |
| 9. Jing Wang, Peng Xue, Jiahua Zhou, Lin Li, Lu Xu, Yongjun Wang. (2016) Comparison of two kinds of docetaxel-vitamin E prodrugs: In vitro evaluation and in vivo antitumor activity. INTERNATIONAL JOURNAL OF PHARMACEUTICS, [PMID:27085643] [10.1016/j.ijpharm.2016.03.057] |
| 10. Gu Lina, Sun Ying, Bai Tingjie, Shao Sijie, Tang Shumin, Xue Panpan, Cai Wanlin, Qin Xian, Zeng Xuemei, Yan Shuangqian. (2025) Functional nanozyme system for synergistic tumor immunotherapy via cuproptosis and ferroptosis activation. JOURNAL OF NANOBIOTECHNOLOGY, 23 (1): (1-20). [PMID:40089774] [10.1186/s12951-025-03284-3] |
| 11. Xue Panpan, Zhuang Huilan, Bai Tingjie, Zeng Xuemei, Deng Jinpeng, Shao Sijie, Yan Shuangqian. (2024) Iron (II)-based metal-organic framework nanozyme for boosting tumor ferroptosis through inhibiting DNA damage repair and system Xc-. JOURNAL OF NANOBIOTECHNOLOGY, 22 (1): (1-16). [PMID:38715049] [10.1186/s12951-024-02508-2] |
| 12. Chen Yukun, Chen Yuanyuan, Wang Zhenzhi, Yang Lian, Zhang Yu, Zhang Zhanxia, Jia Lijun. (2024) Iron-based MOF with Catalase-like activity improves the synergistic therapeutic effect of PDT/ferroptosis/starvation therapy by reversing the tumor hypoxic microenvironment. JOURNAL OF NANOBIOTECHNOLOGY, 22 (1): (1-18). [PMID:39543666] [10.1186/s12951-024-02921-7] |
| 13. Zhiyuan Liu, Yaxuan Huang, Rui Sun, Nan Li, Fengyun Xu, Wei Zhang, Wenke Zhang. (2025) Polyethylene Glycolated Shikonin-Functionalized Carbon Nanotubes as an Effective Anticancer System Combining Chemotherapy and Photothermal Therapy. LANGMUIR, [PMID:40015981] [10.1021/acs.langmuir.4c05257] |
| 14. Zhiyuan Liu, Rui Sun, Yaxuan Huang, Fengyun Xu, Nan Li, Wei Zhang, Pengfei Ge, Wenke Zhang. (2024) The preparation of shikonin-based nanomedicine with robust GSH-responsiveness. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, [PMID:] [10.1016/j.colsurfa.2024.135557] |
| 15. Huahui Zeng, Man Li, Zhirong Wang, Tianqi Wang, Zhenqiang Zhang, Xiangxiang Wu. (2024) Disulfide bond-based oxidation-responsive triptolide-loaded nanodrug for inflammation-targeted treatment of collagen-induced arthritis. Applied Materials Today, [PMID:] [10.1016/j.apmt.2024.102350] |
| 16. Qianqian Qi, Zhanyu Zhang, Dun Wang. (2025) GSH-responsive paclitaxel prodrug used in chemotherapy in combination with photodynamic therapy. BIOORGANIC CHEMISTRY, [PMID:40007348] [10.1016/j.bioorg.2025.108289] |
| 17. Wentao Lei, Yinghui Wang, Tangyue Zheng, Qihang Wu, Hui Wen, Tingting Sun, Jun Liu, Zhigang Xie. (2025) NIR-II photothermal therapy combined with activatable immunotherapy against the recurrence and metastasis of orthotopic triple-negative breast cancer. Nanoscale, [PMID:39964003] [10.1039/D4NR04981K] |
| 18. Chao Han, Can Zhang, Ting Ma, Chao Zhang, Jianguang Luo, Xiao Xu, Huijun Zhao, Yan Chen, Lingyi Kong. (2018) Hypericin-functionalized graphene oxide for enhanced mitochondria-targeting and synergistic anticancer effect. Acta Biomaterialia, [PMID:30006311] [10.1016/j.actbio.2018.07.018] |
| 19. Huiyun Zhang, Wenqian Xu, Emmanuel Omari-Siaw, Yingkun Liu, Baoding Chen, Deyu Chen, Jiangnan Yu, Ximing Xu. (2017) Redox-responsive PEGylated self-assembled prodrug-nanoparticles formed by single disulfide bond bridge periplocymarin-vitamin E conjugate for liver cancer chemotherapy. DRUG DELIVERY, [PMID:28835137] [10.1080/10717544.2017.1365393] |
| 20. Hui-Yun Zhang, Cong-yong Sun, Michael Adu-Frimpong, Jiang-nan Yu, Xi-ming Xu. (2018) Glutathione-sensitive PEGylated curcumin prodrug nanomicelles: Preparation, characterization, cellular uptake and bioavailability evaluation. INTERNATIONAL JOURNAL OF PHARMACEUTICS, [PMID:30471374] [10.1016/j.ijpharm.2018.11.049] |
| 21. Panpan Xue, Huilan Zhuang, Sijie Shao, Hai Cai, Shumin Tang, Ying Sun, Xuemei Zeng, Shuangqian Yan. (2025) Biodegradable ionic nanoregulators for synchronous modulation of copper and iron ion homeostasis in breast cancer therapy. CHEMICAL ENGINEERING JOURNAL, [PMID:] [10.1016/j.cej.2025.162041] |
| 22. Luyao Yang, Rong Liu, Meiying Xie, Fan Yang. (2025) Construction of a MIL-101-DGA (MOF) Coupling Betaine Hydrochloride System for the Green and Efficient Separation of Zirconium and Hafnium. ACS Applied Materials & Interfaces, [PMID:40209173] [10.1021/acsami.5c02082] |
| 23. Hongkai Fang, Jingxuan Zhang, Jialin Xing, Yuebin Dai, Yanzhong Hao, Wenjing Wang, Zhiyu Kuang, Mingyang Han, Zhonggui He, Bingjun Sun, Jin Sun. (2026) Optimizing doxorubicin prodrug albumin nanoparticles through tailored alkyl chain lengths and optimized linker chemistry. Nano Today, [PMID:] [10.1016/j.nantod.2026.103034] |
| 24. Haipeng Lin, Zhifeng Hao, Xiang Chen, Jian Yu, Kai Yan, Jingbo Li, Tong Wang, Changyou Ren, Hong Liu. (2026) High-quality gold electrodeposition from a cyanide-free sulfite bath: synergistic effect of dithiodiglycolic acid and a trace inorganic modulator. APPLIED SURFACE SCIENCE, [PMID:] [10.1016/j.apsusc.2026.166746] |